2015年中国山东省不同甲型肝炎免疫策略覆盖人群的甲型肝炎抗体流行率
2015年10月在山东省采用分层随机抽样调查1654名≤7岁至≥35岁人群,用ELISA检测抗-HAV IgG。粗阳性率91.41%(1512/1654,95%CI:89.96%-92.72%),标化率90.93%(95%CI:90.92%-90.94%);≤7岁组最高(95.90%,95%CI:95.88%-95.91%),25~34岁组最低(83.23%,95%CI:83.21%-83.25%);东部地区(96.79%,95%CI:96.78%-96.80%)高于中部(86.66%,95%CI:86.65%-86.67%)和西部(91.96%,95%CI:91.95%-91.97%)。结论认为山东省人群抗-HAV IgG阳性率较高但青壮年偏低。
要点
- 山东省2015年人群抗-HAV IgG粗阳性率91.41%(1512/1654),标化率90.93%。
- ≤7岁组标化率最高95.90%,25~34岁组最低83.23%。
- 东部地区标化率96.79%,高于中部86.66%和西部91.96%。
核心结论
- 山东省人群抗-HAV IgG阳性率水平较高,但青壮年偏低;建议在做好儿童甲型肝炎疫苗接种的同时,加强青壮年特别是中部和西部地区青壮年人群甲型肝炎防制工作。
研究设计与样本
- 2015年10月按山东省地理位置分层,将17个设区的市分层后用随机数字表法抽样,选取东部2市(青岛、日照)、西部2市(聊城、枣庄)和中部3市(济南、淄博、莱芜),每市抽取1个县,每县抽取2个乡镇,共调查1654名。
主要发现
- 最终分析1654人,男性856名(51.75%),女性798名(48.25%),年龄(13.44±13.06)岁。
- 抗-HAV IgG粗阳性率为91.41%(1512/1654,95%CI:89.96%-92.72%),标化率为90.93%(95%CI:90.92%-90.94%)。
- ≤7岁组标化率最高(95.90%,95%CI:95.88%-95.91%),25~34岁组最低(83.23%,95%CI:83.21%-83.25%)。
- 东部地区标化率(96.79%,95%CI:96.78%-96.80%)高于中部(86.66%,95%CI:86.65%-86.67%)和西部(91.96%,95%CI:91.95%-91.97%)。
关键数值与推荐
- ≤7岁(甲型肝炎疫苗免费接种儿童)、8~11岁(甲型肝炎疫苗自费接种儿童)、12~24岁(甲型肝炎疫苗查漏补种人群)、25~34岁和≥35岁(甲型肝炎疫苗使用前出生人群)为调查对象。
- 采用ELISA方法检测血清抗-HAV IgG,采用2015年山东省统计年鉴数据以及2010年全国人口普查数据进行标化。
临床怎么用
- 作者建议在做好儿童甲型肝炎疫苗接种的同时,加强青壮年特别是中部和西部地区青壮年人群甲型肝炎防制工作。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate prevalence of hepatitis A antibody (anti-HAV IgG) among population covered by different hepatitis A vaccine immunization strategies in Shandong Province in 2015. Methods: In October 2015, according to the geographical location of Shandong Province, the stratified random sampling method was used to stratify the 17 municipal distrcts, and the random number table method was used for sampling, First, two eastern cites (Qingdao, Rizhao), two western cities (Liaocheng, Zaozhuang) and three central cities (Jinan, Zibo and Laiwu) were selected; secondly, one county was drawn from each city. Finally, the participants were divided into five age groups including ≤7 years (age group covered by free hepatitis A vaccination strategy), 8-11 years (age group who receive hepatitis A vaccination at their own charge), 12-24 years (age group covered by catch-up vaccination of hepatitis A), 25-34 years (age group born before hepatitis A vaccine was used) and ≥35 years (age group born before hepatitis A vaccine was used). After all the paticipants or their guardians asked and registered basic information such as age, gender, home address, blood samples were collected from them and anti-HAV IgG was detected by ELISA method. The positive rate of anti-HAV IgG and 95%CI were calculated. Results: A total of 1 654 participants were involved in the final analysis, including 856 males (51.75%) and 798 females (48.25%) whose mean age was (13.44±13.06) years. The crude positive rate of anti-HAV IgG was 91.41% (1 512/1 654, 95%CI: 89.96%-92.72%) and the age-adjusted rate was 90.93% (95%CI: 90.92%-90.94%). The positive rates of anti-HAV IgG was at the highest level in the age group of ≤7 years (95.90%, 95%CI: 95.88%-95.91%) and was at the lowest level in the age group of 25-34 years (83.23%, 95%CI: 83.21%-83.25%). The age-specific positive rates of anti-HAV IgG in eastern areas (96.79%, 95%CI: 96.78%-96.80%) were higher than those in both middle areas (86.66%, 95%CI: 86.65%-86.67%) and western areas (91.96%, 95%CI: 91.95%-91.97%). Conclusion: The positive rate of anti-HAV IgG was high among the general population in Shandong Province, but relatively low among young and middle-aged adults. Besides the routine immunization of hepatitis A among the children, more efforts should be taken for the prevention and control of hepatitis A among young and middle-aged adults in Shandong Province, especially in central and western areas. 目的: 分析山东省社区人群甲型肝炎抗体(抗-HAV IgG)水平。 方法: 于2015年10月,根据山东省地理位置,采用分层抽样方法将17个设区的市分层后,采用随机数字表法进行抽样。首先,选择2个东部市(青岛、日照),2个西部市(聊城、枣庄)和3个中部市(济南、淄博、莱芜);其次,每市抽取1个县,每县抽取2个乡镇;最后,以所有乡镇中≤7岁(甲型肝炎疫苗免费接种儿童)、8~11岁(甲型肝炎疫苗自费接种儿童)、12~24岁(甲型肝炎疫苗查漏补种人群)、25~34岁(甲型肝炎疫苗使用前出生人群)和≥35岁(甲型肝炎疫苗使用前出生人群)人群为调查对象,共调查了1 654名。调查年龄、性别、家庭住址等基本信息后,采集其血清标本。采用ELISA方法检测血清抗-HAV IgG。采用2015年山东省统计年鉴数据以及2010年全国人口普查数据进行标化后,计算抗-HAV IgG阳性标化率(标化率)与95%CI值。 结果: 1 654名调查对象中,男性856名(51.75%),女性798名(48.25%),年龄为(13.44±13.06)岁。抗-HAV IgG阳性率为91.41%(1 512例),标化率为90.93%(95%CI: 90.92%~90.94%);≤7岁组标化率最高(95.90%,95%CI: 95.88%~95.91%),25~34岁组最低(83.23%,95%CI: 83.21%~83.25%);东部地区标化率(96.79%,95% CI: 96.78%~96.80%)高于中部(86.66%,95% CI: 86.65%~86.67%)和西部(91.96%,95%CI: 91.95%~91.97%)。 结论: 山东省人群抗-HAV IgG阳性率水平较高,但青壮年偏低。建议在做好儿童甲型肝炎疫苗接种的同时,加强青壮年特别是中部和西部地区青壮年人群甲型肝炎防制工作。.
引用
- Kong Q, Yan BY, Lyu JJ, et al. [Prevalence of hepatitis A antibody among population covered by different hepatitis A immunization strategies in Shandong Province, 2015, China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2017. PMID: 28592089. doi:10.3760/cma.j.issn.0253-9624.2017.06.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。